BridgeMD
Compares treatment options for Type 1 Diabetes
Official title Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes
ClinicalTrials.gov ID: NCT05188027
What this study is testing
- What it's testing
- Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75, women only
You may be able to join if
- type 1 diabetes, diagnosed for at least one year
- post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
- able to perform aerobic and resistance exercise
- able to visit the lab in Edmonton, Alberta (University of Alberta)
You likely can't join if
- HbA1c \> 9.9 %
- frequent and unpredictable hypoglycemia
- change in insulin management strategy within the last 2 months
- blood pressure \> 140 / 95
- severe peripheral neuropathy
- history of cardiovascular disease
See the full eligibility criteria
- type 1 diabetes, diagnosed for at least one year
- post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
- able to perform aerobic and resistance exercise
- able to visit the lab in Edmonton, Alberta (University of Alberta)
- HbA1c \> 9.9 %
- frequent and unpredictable hypoglycemia
- change in insulin management strategy within the last 2 months
- blood pressure \> 140 / 95
- severe peripheral neuropathy
- history of cardiovascular disease
- musculoskeletal injuries interfering with exercise performance
- use of medications (other than insulin) that affect glucose metabolism
- BMI \> 30 kg/m2
- smoking
- moderate to high alcohol intake (\> 2 drinks/day)
The study team makes the final eligibility decision.
Where it's taking place
- Edmonton, Alberta, Canada
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edmonton, Alberta, Canada; Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.